This study revealed that ALKBH5 increases glycolysis in drug-resistant breast cancer cells by promoting m6A demethylation of GLUT4 messenger RNA (mRNA), thereby increasing GLUT4 expression[31]. The gene discussed is SLC2A4; the disease is breast carcinoma.